NDC 0404-9924
Naropin 5 mg per 1 mL injection, solution
On the label: Henry Schein, Inc.. It's repackaged: Henry Schein, Inc. rebottles it from Fresenius Kabi, LLC's NDC 63323-286.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Fresenius Kabi Austria | Austria 8055, Austria | Makes it, tests it and packages it | Problems found, fixed voluntarilyMar 21, 2024 · 9 inspections |
| Fresenius Kabi USA, LLC | Melrose Park, IL, United States | Makes it and tests it | Problems found, fixed voluntarilyAug 24, 2023 · 13 inspections, 2 with FDA action |
| HP Halden Pharma AS | Halden, Norway | Makes it, tests it and packages it | Problems found, fixed voluntarilyMay 10, 2023 · 7 inspections |
Recalls
- Jul 16, 2026 · Class II · Fresenius Kabi USA, LLC
Presence of Particulate Matter: Hair was found in products
Lots: Lot #: 6133436, Exp. Date 10/2028
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ropivacaine: every company that makes it
- Form
- injection, solution, epidural; infiltration; perineural
- Strength
- 5 mg per 1 mL
- Approval
- NDA NDA020533
- On the market since
- Jan 13, 2022
- Package NDCs
0404-9924-30- Official label
- DailyMed (National Library of Medicine), updated Jul 22, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?